• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
/
Back to catalog
Home / Products / Ceftriaxone + Water for injection

Ceftriaxone + Water for injection

1 vial and 1 ampoule
Group of action
Antimicrobial agents for systemic use
Active ingredient
Ceftriaxone
Dosage form
Powder for solution for injections
ATC code
J01D D04
RX/OTC
RX
Marketing authorisation no.
UA/13240/01/01
Download instruction leaflet in PDF

General properties

Pharmacotherapeutic group

Antibacterials for systemic use. Other beta-lactam antibacterials. Third-generation cephalosporins. Ceftriaxone. 

Indications

Ceftriaxone is indicated for the treatment of the following infections when caused by susceptible bacteria:

  • respiratory tract infections, especially pneumonia, and ear, throat and nose infections;
  • abdominal infections (peritonitis, biliary and gastrointestinal infections);
  • renal and urinary infections;
  • genital infections, including gonorrhea;
  • sepsis;
  • bone, joint, soft tissue, skin, and wound infections;
  • infection in immune compromised patient;
  • meningitis;
  • disseminated Lyme borreliosis (stage II and stage III);

Perioperative prevention of infections during surgical interventions on the gastrointestinal tract, bile ducts, urinary tracts and during gynecological procedures, but only in cases of potential or known contamination.

Consideration should be given to official guidelines on the appropriate use of antibacterial agents, in particular, recommendations for the prevention of antibiotic resistance. 

Contraindications

Hypersensitivity to ceftriaxone, to any other cephalosporin. History of severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (penicillins, monobactams and carbapenems). Ceftriaxone is contraindicated in: Premature neonates up to a postmenstrual age of ≤41 weeks (gestational age + chronological age)*. Full-term neonates (up to 28 days of age): with hyperbilirubinaemia, jaundice, or who are hypoalbuminaemic or acidotic because these are conditions in which bilirubin binding is likely to be impaired*; if they require (or are expected to require) intravenous calcium treatment, or calcium-containing infusions due to the risk of precipitation of ceftriaxone-calcium salt (see sections “Special warnings and precautions for use” and “Undesirable effects”). * In vitro studies have shown that Ceftriaxone can displace bilirubin from its serum albumin binding sites leading to a possible risk of bilirubin encephalopathy in these patients.

Pharmaceutical characteristics

Basic physical and chemical properties

White or off-white crystalline powder.

Shelf life
3 years.
Storage conditions

Store in original package at temperature not exceeding 25 °С. Keep out of reach of children.

By prescription.
Manufacturer
JSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
Back to catalog
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2021. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту